{
    "xml": "<topic id=\"PHP5679\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/interferon-beta\" basename=\"interferon-beta\" title=\"INTERFERON BETA\">\n<title>INTERFERON BETA</title>\n<body>\n<data name=\"vtmid\">108749003</data>\n<data name=\"vtmid\">108751004</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_998292074\" title=\"Interferons\">Interferons</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n</body>\n<topic id=\"PHP46342\" outputclass=\"contraindications\" rev=\"1.10\" parent=\"/drugs/interferon-beta\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Decompensated liver disease</ph>; <ph outputclass=\"contraindication\">severe depressive illness</ph>\n</p>\n</section>\n<section outputclass=\"importantAdvice\">\n<title>Contra-indications, further information</title>\n<sectiondiv>\n<p>Consult product literature for further information on contra-indications.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP46351\" outputclass=\"cautions\" rev=\"1.26\" parent=\"/drugs/interferon-beta\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">History of cardiac disorders</ph>; <ph outputclass=\"caution\">history of depressive disorders (avoid in severe depression or in those with suicidal ideation)</ph>; <ph outputclass=\"caution\">history of seizures</ph>; <ph outputclass=\"caution\">history of severe myelosupression</ph>\n</p>\n</section>\n<section outputclass=\"importantAdvice\">\n<title>Cautions, further information</title>\n<sectiondiv>\n<p>Consult product literature for further information on cautions.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP46253\" outputclass=\"sideEffects\" rev=\"1.19\" parent=\"/drugs/interferon-beta\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Alopecia</ph>; <ph outputclass=\"sideEffect\">anaphylaxis</ph>; <ph outputclass=\"sideEffect\">blood disorders</ph>; <ph outputclass=\"sideEffect\">chills</ph>; <ph outputclass=\"sideEffect\">confusion</ph>; <ph outputclass=\"sideEffect\">convulsions</ph>; <ph outputclass=\"sideEffect\">fever</ph>; <ph outputclass=\"sideEffect\">hepatitis</ph>; <ph outputclass=\"sideEffect\">hypersensitivity reactions</ph>; <ph outputclass=\"sideEffect\">influenza-like symptoms (decreasing over time)</ph>; <ph outputclass=\"sideEffect\">irritation at injection site (including inflammation, hypersensitivity, necrosis)</ph>; <ph outputclass=\"sideEffect\">malaise</ph>; <ph outputclass=\"sideEffect\">menstrual disorders</ph>; <ph outputclass=\"sideEffect\">mood and personality changes</ph>; <ph outputclass=\"sideEffect\">myalgia</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">nephrotic syndrome</ph>; <ph outputclass=\"sideEffect\">suicide attempts</ph>; <ph outputclass=\"sideEffect\">thrombotic microangiopathy</ph>; <ph outputclass=\"sideEffect\">thyroid dysfunction</ph>; <ph outputclass=\"sideEffect\">urticaria</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p>Also consult product literature for all side effects.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP46345\" outputclass=\"conceptionAndContraception\" parent=\"/drugs/interferon-beta\">\n<title>Conception and contraception</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Effective contraception required during treatment&#8212;consult product literature.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP46295\" outputclass=\"pregnancy\" parent=\"/drugs/interferon-beta\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid unless potential benefit outweighs risk (toxicity in <i>animal</i> studies).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP46354\" outputclass=\"breastFeeding\" parent=\"/drugs/interferon-beta\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid&#8212;no information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP46319\" outputclass=\"hepaticImpairment\" parent=\"/drugs/interferon-beta\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Caution in severe hepatic impairment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP46273\" outputclass=\"renalImpairment\" parent=\"/drugs/interferon-beta\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Caution in severe renal impairment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP46218\" outputclass=\"monitoringRequirements\" parent=\"/drugs/interferon-beta\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Monitor for signs of hepatic injury&#8212;hepatic failure has been reported rarely.</p>\n</sectiondiv>\n<sectiondiv>\n<p>Patients should be monitored for clinical features of thrombotic microangiopathy (TMA), including thrombocytopenia, new onset hypertension, fever, central nervous system symptoms (e.g. confusion and paresis), and impaired renal function. Any signs of TMA should be investigated fully and, if diagnosed, interferon beta should be stopped immediately and treatment for TMA promptly initiated (consult product literature for details).</p>\n</sectiondiv>\n<sectiondiv>\n<p>Patients should also be monitored for signs and symptoms of nephrotic syndrome, including oedema, proteinuria, and impaired renal function&#8212;monitor renal function periodically. If nephrotic syndrome develops, treat promptly and consider stopping interferon beta treatment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP46197\" outputclass=\"nationalFunding\" rev=\"1.15\" parent=\"/drugs/interferon-beta\">\n<title>National funding/access decisions</title>\n<body>\r\n<section>\r\n<sectiondiv outputclass=\"niceTechnologyAppraisals\">\r\n<p outputclass=\"title\">NICE technology appraisals (TAs)</p>\r\n<sectiondiv outputclass=\"niceTechnologyAppraisal\">\r\n<p outputclass=\"fundingIdentifier\">NICE TA32</p>\r\n<sectiondiv>\r\n<p outputclass=\"title\">Interferon beta and glatiramer for multiple sclerosis (January 2002)</p>\r\n<p>Interferon beta and glatiramer acetate are <b>not</b> recommended for the treatment of multiple sclerosis in the NHS in England and Wales.</p>\r\n<p>Patients who are currently receiving interferon beta or glatiramer acetate for multiple sclerosis, whether as routine therapy or as part of a clinical trial, should have the option to continue treatment until they and their consultant consider it appropriate to stop, having regard to the established criteria for withdrawal from treatment.</p>\n</sectiondiv>\n<xref format=\"html\" href=\"http://www.nice.org.uk/TA32\">www.nice.org.uk/TA32</xref>\n</sectiondiv>\n</sectiondiv>\r\n </section>\r\n<section outputclass=\"nonNHS\">\r\n<title>NHS restrictions</title>\r\n<sectiondiv>\r\n<p outputclass=\"title\">Provision of disease-modifying therapies for multiple sclerosis</p>\r\n<p>The Department of Health, the National Assembly for Wales, the Scottish Executive, the Northern Ireland Department of Health, Social Services &amp; Public Safety, and the manufacturers have reached agreement on a risk-sharing scheme for the NHS supply of interferon beta and glatiramer acetate for multiple sclerosis. Health Service Circular (HSC 2002/004) explains how patients can participate in the scheme. It is available on the Department of Health website (<xref format=\"html\" href=\"http://www.dh.gov.uk\">www.dh.gov.uk</xref>).</p>\n</sectiondiv>\n</section>\r\n</body>\n</topic>\n<topic id=\"PHP5679-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/interferon-beta\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75240\" title=\"Solution for injection\" namespace=\"/drugs/interferon-beta/solution-for-injection\">Solution for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75233\" title=\"Powder and solvent for solution for injection\" namespace=\"/drugs/interferon-beta/powder-and-solvent-for-solution-for-injection\">Powder and solvent for solution for injection</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75240\" namespace=\"/drugs/interferon-beta/solution-for-injection\" title=\"Solution for injection\" count=\"1\" rel=\"link\">Solution for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75233\" namespace=\"/drugs/interferon-beta/powder-and-solvent-for-solution-for-injection\" title=\"Powder and solvent for solution for injection\" count=\"1\" rel=\"link\">Powder and solvent for solution for injection</xref>\n</links>\n</topic>",
    "id": "PHP5679",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/interferon-beta",
    "basename": "interferon-beta",
    "title": "INTERFERON BETA",
    "vtmid": "108751004",
    "drugClassification": [
        "Interferons"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Decompensated liver disease",
                "html": "Decompensated liver disease"
            },
            {
                "type": "contraindications",
                "textContent": "severe depressive illness",
                "html": "severe depressive illness"
            }
        ],
        "importantAdvice": [
            {
                "type": "importantAdvice",
                "textContent": "Consult product literature for further information on contra-indications.",
                "html": "<p>Consult product literature for further information on contra-indications.</p>"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "History of cardiac disorders",
                "html": "History of cardiac disorders"
            },
            {
                "type": "cautions",
                "textContent": "history of depressive disorders (avoid in severe depression or in those with suicidal ideation)",
                "html": "history of depressive disorders (avoid in severe depression or in those with suicidal ideation)"
            },
            {
                "type": "cautions",
                "textContent": "history of seizures",
                "html": "history of seizures"
            },
            {
                "type": "cautions",
                "textContent": "history of severe myelosupression",
                "html": "history of severe myelosupression"
            }
        ],
        "importantAdvice": [
            {
                "type": "importantAdvice",
                "textContent": "Consult product literature for further information on cautions.",
                "html": "<p>Consult product literature for further information on cautions.</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Alopecia",
                        "html": "Alopecia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "anaphylaxis",
                        "html": "anaphylaxis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "blood disorders",
                        "html": "blood disorders",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "chills",
                        "html": "chills",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "confusion",
                        "html": "confusion",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "convulsions",
                        "html": "convulsions",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "fever",
                        "html": "fever",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hepatitis",
                        "html": "hepatitis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hypersensitivity reactions",
                        "html": "hypersensitivity reactions",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "influenza-like symptoms (decreasing over time)",
                        "html": "influenza-like symptoms (decreasing over time)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "irritation at injection site (including inflammation, hypersensitivity, necrosis)",
                        "html": "irritation at injection site (including inflammation, hypersensitivity, necrosis)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "malaise",
                        "html": "malaise",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "menstrual disorders",
                        "html": "menstrual disorders",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "mood and personality changes",
                        "html": "mood and personality changes",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "myalgia",
                        "html": "myalgia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nephrotic syndrome",
                        "html": "nephrotic syndrome",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "suicide attempts",
                        "html": "suicide attempts",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "thrombotic microangiopathy",
                        "html": "thrombotic microangiopathy",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "thyroid dysfunction",
                        "html": "thyroid dysfunction",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "urticaria",
                        "html": "urticaria",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "textContent": "Also consult product literature for all side effects.",
                "html": "<p>Also consult product literature for all side effects.</p>"
            }
        ]
    },
    "conceptionAndContraception": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Effective contraception required during treatment&#8212;consult product literature.",
                "html": "<p>Effective contraception required during treatment&#8212;consult product literature.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid unless potential benefit outweighs risk (toxicity in animal studies).",
                "html": "<p>Avoid unless potential benefit outweighs risk (toxicity in <i>animal</i> studies).</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid&#8212;no information available.",
                "html": "<p>Avoid&#8212;no information available.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Caution in severe hepatic impairment.",
                "html": "<p>Caution in severe hepatic impairment.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Caution in severe renal impairment.",
                "html": "<p>Caution in severe renal impairment.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Monitor for signs of hepatic injury&#8212;hepatic failure has been reported rarely.",
                "html": "<p>Monitor for signs of hepatic injury&#8212;hepatic failure has been reported rarely.</p>"
            },
            {
                "type": "patientParameters",
                "textContent": "Patients should be monitored for clinical features of thrombotic microangiopathy (TMA), including thrombocytopenia, new onset hypertension, fever, central nervous system symptoms (e.g. confusion and paresis), and impaired renal function. Any signs of TMA should be investigated fully and, if diagnosed, interferon beta should be stopped immediately and treatment for TMA promptly initiated (consult product literature for details).",
                "html": "<p>Patients should be monitored for clinical features of thrombotic microangiopathy (TMA), including thrombocytopenia, new onset hypertension, fever, central nervous system symptoms (e.g. confusion and paresis), and impaired renal function. Any signs of TMA should be investigated fully and, if diagnosed, interferon beta should be stopped immediately and treatment for TMA promptly initiated (consult product literature for details).</p>"
            },
            {
                "type": "patientParameters",
                "textContent": "Patients should also be monitored for signs and symptoms of nephrotic syndrome, including oedema, proteinuria, and impaired renal function&#8212;monitor renal function periodically. If nephrotic syndrome develops, treat promptly and consider stopping interferon beta treatment.",
                "html": "<p>Patients should also be monitored for signs and symptoms of nephrotic syndrome, including oedema, proteinuria, and impaired renal function&#8212;monitor renal function periodically. If nephrotic syndrome develops, treat promptly and consider stopping interferon beta treatment.</p>"
            }
        ]
    },
    "nationalFunding": {
        "niceTechnologyAppraisals": [
            {
                "type": "niceTechnologyAppraisals",
                "references": [
                    {
                        "id": "http://www.nice.org.uk/TA32",
                        "label": "www.nice.org.uk/TA32"
                    }
                ],
                "fundingIdentifier": "NICE TA32",
                "textContent": "Interferon beta and glatiramer for multiple sclerosis (January 2002) Interferon beta and glatiramer acetate are not recommended for the treatment of multiple sclerosis in the NHS in England and Wales. Patients who are currently receiving interferon beta or glatiramer acetate for multiple sclerosis, whether as routine therapy or as part of a clinical trial, should have the option to continue treatment until they and their consultant consider it appropriate to stop, having regard to the established criteria for withdrawal from treatment.\n\nwww.nice.org.uk/TA32",
                "html": "<p outputclass=\"title\">Interferon beta and glatiramer for multiple sclerosis (January 2002)</p> <p>Interferon beta and glatiramer acetate are <b>not</b> recommended for the treatment of multiple sclerosis in the NHS in England and Wales.</p> <p>Patients who are currently receiving interferon beta or glatiramer acetate for multiple sclerosis, whether as routine therapy or as part of a clinical trial, should have the option to continue treatment until they and their consultant consider it appropriate to stop, having regard to the established criteria for withdrawal from treatment.</p><xref format=\"html\" href=\"http://www.nice.org.uk/TA32\">www.nice.org.uk/TA32</xref>"
            }
        ],
        "nonNHS": [
            {
                "type": "nonNHS",
                "references": [
                    {
                        "id": "http://www.dh.gov.uk",
                        "label": "www.dh.gov.uk"
                    }
                ],
                "title": "Provision of disease-modifying therapies for multiple sclerosis",
                "textContent": "The Department of Health, the National Assembly for Wales, the Scottish Executive, the Northern Ireland Department of Health, Social Services & Public Safety, and the manufacturers have reached agreement on a risk-sharing scheme for the NHS supply of interferon beta and glatiramer acetate for multiple sclerosis. Health Service Circular (HSC 2002/004) explains how patients can participate in the scheme. It is available on the Department of Health website (www.dh.gov.uk).",
                "html": "<p>The Department of Health, the National Assembly for Wales, the Scottish Executive, the Northern Ireland Department of Health, Social Services &amp; Public Safety, and the manufacturers have reached agreement on a risk-sharing scheme for the NHS supply of interferon beta and glatiramer acetate for multiple sclerosis. Health Service Circular (HSC 2002/004) explains how patients can participate in the scheme. It is available on the Department of Health website (<xref format=\"html\" href=\"http://www.dh.gov.uk\">www.dh.gov.uk</xref>).</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75240",
                "label": "Solution for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75233",
                "label": "Powder and solvent for solution for injection",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ]
    },
    "links": {
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75240",
                "label": "Solution for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75233",
                "label": "Powder and solvent for solution for injection",
                "type": "medicinalForm"
            }
        ]
    }
}